Anti-inflammatory treatment improves high-density lipoprotein function in rheumatoid arthritis
F. Anthony O’Neill(Queen's University Belfast), John Deanfield(Universidad de Londres), Emma Sutill(University College London), Christopher W. M. Kay(London Centre for Nanotechnology), Neha Patel(University College London), Ulf Landmesser(Deutsches Herzzentrum der Charité), Marietta Charakida(King's College London), Eric Topham(London Centre for Nanotechnology), Peter C. Taylor(Nuffield Orthopaedic Centre), Francesco D’Aiuto(Eastman Dental Hospital)
Cited by 64
Related Papers
Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
|The Lancet|1992|4.8k
Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery
|Journal of the American College of Cardiology|2002|4.6k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
|European Heart Journal|2016|3.2k
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
|European Heart Journal|2017|3k